Tania Tuya is a pricing and market access expert with extensive experience in the pharmaceutical and biotechnology industries.
She acquired in-depth knowledge from over 14 years’ experience at different levels ranging from HQ functions to affiliate operations (notably France, Spain, Brazil) in companies such as Sanofi, Takeda, Shire, Clovis Oncology and others before establishing her consultancy services.
Since early 2021, Tania advises clients on the strategy and implementation tactics to put in place for the adoption and timely access to therapies. She also serves as French market access responsible person for Biotechs that do not have local presence.
Her core competences are stakeholder and landscape analysis, access strategy development, value proposition development, management of Health Technology Assessments processes, pricing negotiation and launch preparation. She has experience across a wide range of therapeutic areas and has a strong track record of tackling the unique challenges posed by drugs for rare diseases.
Tania holds a Master in Public Affairs from Sciences-Po Paris and an MSc on Strategy and Management of International Business from ESSEC (Paris).